Patent ID: 11865206
Assignee: EMCURE PHARMACEUTICALS LTD
Field: Pharmaceuticals (Chemistry)
Classification: CPC A | IPC A  C

Claim 0:
1. A method of administering carmustine to a patient consisting of:
(i) providing a carmustine solution consisting of: (a) about 100 mg/mL to about 500 mg/mL of carmustine; and (b) a super refined polysorbate with a peroxide value below 10 meq O2/kg to a person administering carmustine to the patient wherein the carmustine solution has not been reconstituted from a lyophilizate and the carmustine solution is provided in a sealed container that is free of polyvinyl chloride and free of di-2-ethylhexylphthalate;
(ii) adding the carmustine solution of step (i) directly to 500 ml of a 0.9% sodium chloride injection solution or 500 ml of a 5% dextrose injection solution to form an administrable solution without any prior dissolution or prior dilution of the carmustine solution; and
(iii) parenterally administering the administrable solution of step (ii) to the patient.